Overview
Most metabolic-research compounds in this catalog are incretin-system agonists (GLP-1, GIP, and glucagon-receptor ligands) and related signaling molecules. The published literature studies them for metabolic and body-composition research endpoints. This guide describes how the compound is characterized and what that research covers. It is not usage guidance and makes no claim about outcomes from use.
A small-molecule NNMT (nicotinamide N-methyltransferase) inhibitor studied in adipocyte and metabolic research. Not a peptide.
Evidence at a glance: Preclinical (animal) evidence
The cited evidence here is preclinical animal-model work, with limited or no human-trial data. Read the research profile accordingly.
Molecular identity
- Molecular formula
- C11H13N2 (cation)
- Molecular weight
- 189.24 g/mol
- CAS number
- 42464-96-0
- Appearance
- Off-white crystalline powder
- Purity (HPLC)
- 99.1%
Researched mechanism
Inhibits NNMT, studied for downstream effects on cellular NAD+ and adipocyte metabolism.
Described as a mechanism characterized in the literature, not an effect you should expect from use.
What the published research shows
NNMT inhibition and metabolic effects shown in preclinical models.
Honest note on evidence: No published human trials; evidence is preclinical/mechanistic.
Every citation states its study type and population, so preclinical data is never presented as human-efficacy evidence.
How it compares
| Versus | Attribute | Note |
|---|---|---|
| NAD+ | Pathway | Both touch NAD+ biology from different directions (synthesis vs salvage). |
Reconstitution
Concentration math only: adding bacteriostatic water to the vial gives the resulting mg/mL shown below. This is not usage guidance.
| Vial | Bacteriostatic water | Concentration |
|---|---|---|
| 50 mg | — | Supplied as powder; dissolution per research protocol |
| 100 mg | — | Supplied as powder; dissolution per research protocol |
Storage & stability
| State | Temperature | Duration |
|---|---|---|
| Powder (unopened) | Room temp, desiccated | 24 months |
| In solution | 2–8°C | per protocol |
Common questions
Is this a peptide?+
No. It is a small-molecule research chemical (an NNMT inhibitor), included for metabolic-research contexts.
